L-Glutamic γ-monohydroxamate is an antitumor agent that inhibits cancer cell proliferation; it specifically inhibits L-histidine uptake in microvascular endothelial cells; as a vanadium ligand, it activates glucose uptake and metabolism in adipocytes, thereby lowering blood glucose levels.